Information about the shortage of the medicinal product Lamisil dermGel 1% gel (terbinafin)
11.07.2012
Clinres Farmacija d.o.o., the marketing authorisation holder for the medicinal product Lamisil DermGel 1% gel (terbinafin) has informed the Agency for Medicinal products and Medical Devices (HALMED) about the shortage of the aforementioned medicine. The shortage of the medicine stocks is due to an increase in consumtion.
The normalisation of the market supply with the medicinsl product Lamisil DermGel 1% gel is expected in the beginning of September 2012. There is a medicinal product Lamisil 1% cream of the same manufacturer available on the Croatian market, not affected by that shortage.
The public will be proptly informed about the new information about the availability of the medicinal product Lamisil DermGel 1% gel.
